Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP
Publication
, Journal Article
Rouleau, JL; Roecker, EB; Tendera, M; Hernandez, AF
Published in: Evidence-Based Medicine
February 1, 2005
Duke Scholars
Published In
Evidence-Based Medicine
DOI
ISSN
1356-5524
Publication Date
February 1, 2005
Volume
10
Issue
1
Start / End Page
9
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rouleau, J. L., Roecker, E. B., Tendera, M., & Hernandez, A. F. (2005). Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP. Evidence-Based Medicine, 10(1), 9. https://doi.org/10.1136/ebm.10.1.9
Rouleau, J. L., E. B. Roecker, M. Tendera, and A. F. Hernandez. “Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP.” Evidence-Based Medicine 10, no. 1 (February 1, 2005): 9. https://doi.org/10.1136/ebm.10.1.9.
Rouleau JL, Roecker EB, Tendera M, Hernandez AF. Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP. Evidence-Based Medicine. 2005 Feb 1;10(1):9.
Rouleau, J. L., et al. “Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP.” Evidence-Based Medicine, vol. 10, no. 1, Feb. 2005, p. 9. Scopus, doi:10.1136/ebm.10.1.9.
Rouleau JL, Roecker EB, Tendera M, Hernandez AF. Carvedilol reduced mortality and hospital admission in severe chronic heart failure, regardless of pretreatment systolic BP. Evidence-Based Medicine. 2005 Feb 1;10(1):9.
Published In
Evidence-Based Medicine
DOI
ISSN
1356-5524
Publication Date
February 1, 2005
Volume
10
Issue
1
Start / End Page
9
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences